Regeneus IPO nets $10.5m

The biotech company is to float on September 17 after its initial public offering raised $10.5 million at 25 cents a share

Stem cell firm Regeneus (RGS) will float its shares on the Australian Securities Exchange early next week after its initial public offering closed fully subscribed today.

The offer raised $10.5 million at 25 cents a share, slightly higher than its target for $10 million but below the maximum of $12 million Regeneus had allowed for depending on demand.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles